Oxaliplatin News and Research

RSS
FOLFOX now treatment standard for colorectal cancer in the United States

FOLFOX now treatment standard for colorectal cancer in the United States

Chemotherapy options improve for patients with advanced colorectal cancer

Chemotherapy options improve for patients with advanced colorectal cancer

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

Cetuximab (Erbitux) can battle cancer and prolong life in many patients with advanced colorectal cancer

Genetic biomarker that may improve quality of life during treatment for colorectal cancer

Genetic biomarker that may improve quality of life during treatment for colorectal cancer

New cancer drug Avastin keeps cancer under control

New cancer drug Avastin keeps cancer under control

Avastin plus Folfox4 chemotherapy significantly extends survival in second-line metastatic colorectal cancer

Avastin plus Folfox4 chemotherapy significantly extends survival in second-line metastatic colorectal cancer

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Northern Ireland scientists target bowel cancer treatment

Northern Ireland scientists target bowel cancer treatment

NeoRx Corporation acquires worldwide rights to platinum-based anti-cancer agent

NeoRx Corporation acquires worldwide rights to platinum-based anti-cancer agent